Skip to main content

Table 2 Univariable analysis

From: A prospective study examining cachexia predictors in patients with incurable cancer

Univariable analysis
  HR 95% CI p
Age at inclusion 1.01 1.00–1.03 0.06
Gender
 Male 1.5 1.1–2.0 0.01
 Female 1   
 Weight loss (6 months) 1.6 1.4–1.7 <  0.001
BMI 0.99 0.95–1.03 0.53
Karnofsky PS (0–100) 0.98 0.97–1.00 <  0.01
Fatigue (0–100) 1.00 1.00–1.01 0.26
Physical functioning (0–100) 0.99 0.99–1.00 0.09
Emotional functioning (0–100) 1.00 0.99–1.01 0.67
Food intake
 Less than usual 1.7 1.2–2.4 <  0.01
 More than usual 1.0 0.6–1.7 0.93
 Unchanged 1   
Appetite loss (0–100) 1.01 1.01–1.02 <  0.001
Cancer stage
 Metastatic/disseminated 1.7 1.0–2.9 0.07
 Local 1   
Cancer typea
 High risk cancer 4.4 2.4–8.1 <  0.001
 Neutral risk cancer 2.1 1.4–3.1 <  0.001
 Low risk cancer 1   
Heart disease 0.9 0.6–1.3 0.55
Renal disease 1.4 0.6–3.1 0.45
Arthritis 1.4 0.8–2.3 0.22
COPD 1.7 1.1–2.7 0.02
  1. Abbreviations: HR hazard ratio, CI confidence interval, BMI body mass index, PS performance status, COPD chronic obstructive pulmonary disease
  2. aLow risk - Breast cancer, lymphoma, leukaemia; High risk – pancreatic and gastric cancer; Neutral risk - all other cancers